Differentiation therapy targeting indoleamine 2,3‑dioxygenase 1 in glioblastoma cells in vitro
Molecular and Clinical Oncology · 21.07.2026 · 25 (3) · 1-7
DOI: 10.3892/mco.2026.2965 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular and Clinical Oncology, online erschienen am 21.07.2026. Verfasst von Kaoru Nishide und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurological Surgery, Nihon University School of Medicine, Tokyo 173-8610, Japan. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurological Surgery, Nihon University School of Medicine, Tokyo 173-8610, Japan.
Zitieren
APA
Nishide, K., Yamamuro, S., Aida, Y., Ozawa, Y., Sano, E., & Yoshino, A. (2026). Differentiation therapy targeting indoleamine 2,3‑dioxygenase 1 in glioblastoma cells in vitro. Molecular and Clinical Oncology, 25(3), 1-7. https://doi.org/10.3892/mco.2026.2965
Vancouver
Nishide K, Yamamuro S, Aida Y, Ozawa Y, Sano E, Yoshino A. Differentiation therapy targeting indoleamine 2,3‑dioxygenase 1 in glioblastoma cells in vitro. Molecular and Clinical Oncology. 2026;25(3):1-7. doi:10.3892/mco.2026.2965
BibTeX
@article{Nishide2026,
author = {Nishide, Kaoru and Yamamuro, Shun and Aida, Yumi and Ozawa, Yoshinari and Sano, Emiko and Yoshino, Atsuo},
title = {Differentiation therapy targeting indoleamine 2,3‑dioxygenase 1 in glioblastoma cells in vitro},
journal = {Molecular and Clinical Oncology},
year = {2026},
volume = {25},
number = {3},
pages = {1--7},
doi = {10.3892/mco.2026.2965}
}
EUVIMED